Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magic mushroom therapy tested to soothe fear of death in cancer patients

NCT ID NCT06416085

Summary

This study is testing a therapy that combines a single dose of psilocybin (the active compound in 'magic mushrooms') with specialized counseling for people with advanced cancer. The goal is to see if this approach is safe, acceptable, and can help reduce the severe anxiety, depression, and fear of death that often comes with a terminal diagnosis. It involves 15 participants in Ontario who will have therapy sessions before and after taking the psilocybin in a controlled, monitored setting.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Princess Margaret Cancer Centre

    Toronto, Ontario, M5G 2M9, Canada

Conditions

Explore the condition pages connected to this study.